350 related articles for article (PubMed ID: 21666177)
21. Toward rubella elimination in Poland: need for supplemental immunization activities, enhanced surveillance, and further integration with measles elimination efforts.
Zimmerman L; Rogalska J; Wannemuehler KA; Haponiuk M; Kosek A; Pauch E; Plonska E; Veltze D; Czarkowski MP; Buddh N; Reef S; Stefanoff P
J Infect Dis; 2011 Jul; 204 Suppl 1():S389-95. PubMed ID: 21666189
[TBL] [Abstract][Full Text] [Related]
22. Seroepidemiological study of measles after the 1992 nationwide MMR revaccination program in Taiwan.
Chiu HH; Lee CY; Chih TW; Lee PI; Chang LY; Lin YJ; Hsu CM; Huang LM
J Med Virol; 1997 Jan; 51(1):32-5. PubMed ID: 8986946
[TBL] [Abstract][Full Text] [Related]
23. A 24-year review on the epidemiology and control of measles in Singapore, 1981-2004.
Ong G; Hoon HB; Ong A; Chua LT; Kai CS; Tai GK
Southeast Asian J Trop Med Public Health; 2006 Jan; 37(1):96-101. PubMed ID: 16771219
[TBL] [Abstract][Full Text] [Related]
24. [Surveillance of measles in Germany].
Tischer A; Siedler A; Rasch G
Gesundheitswesen; 2001 Nov; 63(11):703-9. PubMed ID: 11713702
[TBL] [Abstract][Full Text] [Related]
25. Measles--Puerto Rico, 1993, and the measles elimination program.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1994 Mar; 43(9):171-3. PubMed ID: 8164642
[TBL] [Abstract][Full Text] [Related]
26. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
Zäch K; Nicoara C; Germann D; Matter L
Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
[TBL] [Abstract][Full Text] [Related]
27. Rubella elimination programme strengthened through measles elimination programme in Catalonia.
Domínguez A; Torner N; Martínez A; Costa J; Plans P; Ciruela P; Salleras L
Vaccine; 2006 Feb; 24(9):1433-7. PubMed ID: 16226357
[TBL] [Abstract][Full Text] [Related]
28. Elimination of measles--South Korea, 2001-2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Apr; 56(13):304-7. PubMed ID: 17410083
[TBL] [Abstract][Full Text] [Related]
29. MMR vaccination and disease elimination: the Finnish experience.
Davidkin I; Kontio M; Paunio M; Peltola H
Expert Rev Vaccines; 2010 Sep; 9(9):1045-53. PubMed ID: 20822347
[TBL] [Abstract][Full Text] [Related]
30. American Academy of Pediatrics. Committee on Infectious Diseases. Age for routine administration of the second dose of measles-mumps-rubella vaccine.
American Academy of Pediatrics. Committee on Infectious Diseases
Pediatrics; 1998 Jan; 101(1 Pt 1):129-33. PubMed ID: 11345975
[TBL] [Abstract][Full Text] [Related]
31. Impact of a measles elimination strategy on measles incidence in Malaysia.
Saraswathy TS; Zahrin HN; Norhashmimi H; Az-Ulhusna A; Zainah S; Rohani J
Southeast Asian J Trop Med Public Health; 2009 Jul; 40(4):742-7. PubMed ID: 19842408
[TBL] [Abstract][Full Text] [Related]
32. Closer to the goal: efforts in measles elimination in Germany 2010.
Siedler A; Mankertz A; Feil F; Ahlemeyer G; Hornig A; Kirchner M; Beyrer K; Dreesman J; Scharkus S; Marcic A; Reiter S; Matysiak-Klose D; Santibanez S; Krause G; Wichmann O
J Infect Dis; 2011 Jul; 204 Suppl 1():S373-80. PubMed ID: 21666187
[TBL] [Abstract][Full Text] [Related]
33. The use of rapid coverage monitoring in the national rubella vaccination campaign, Haiti 2007-2008.
Lacapère F; Magloire R; Danovaro-Holliday MC; Flannery B; Chamoulliet H; Celestin EP
J Infect Dis; 2011 Sep; 204 Suppl 2():S698-705. PubMed ID: 21954269
[TBL] [Abstract][Full Text] [Related]
34. Rehabilitation of the expanded programme on immunization in Sudan following a poliomyelitis outbreak.
ElZein HA; Birmingham ME; Karrar ZA; Elhassan AA; Omer A
Bull World Health Organ; 1998; 76(4):335-41. PubMed ID: 9803584
[TBL] [Abstract][Full Text] [Related]
35. Sustained measles elimination in Australia and priorities for long term maintenance.
Gidding HF; Wood J; MacIntyre CR; Kelly H; Lambert SB; Gilbert GL; McIntyre PB
Vaccine; 2007 May; 25(18):3574-80. PubMed ID: 17300858
[TBL] [Abstract][Full Text] [Related]
36. Progress in measles control--Zambia, 1999-2004.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2005 Jun; 54(23):581-4. PubMed ID: 15959454
[TBL] [Abstract][Full Text] [Related]
37. Potential impacts of schedule changes, waning immunity and vaccine uptake on measles elimination in Australia.
Wood JG; Gidding HF; Heywood A; Macartney K; McIntyre PB; Macintyre CR
Vaccine; 2009 Jan; 27(2):313-8. PubMed ID: 18977272
[TBL] [Abstract][Full Text] [Related]
38. Progress toward sustainable measles mortality reduction--South-East Asia Region, 1999-2002.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2004 Jul; 53(25):559-62. PubMed ID: 15229414
[TBL] [Abstract][Full Text] [Related]
39. Nationwide campaign for vaccination of adults against rubella and measles--Costa Rica, 2001.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(44):976-9. PubMed ID: 11724151
[TBL] [Abstract][Full Text] [Related]
40. Measles and mumps immunization: benefit versus risk factors.
Krugman S
Dev Biol Stand; 1979; 43():253-7. PubMed ID: 520672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
